ArticleScience advances2026

Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor.

Seungmin Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.